Document Detail

Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?
MedLine Citation:
PMID:  17563259     Owner:  NLM     Status:  MEDLINE    
Whether used as primary or secondary prevention, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) can lead to a significant reduction in mortality and morbidity from cardiovascular disease. Given the benefit in halting atherosclerotic disease progression in patients with stable and acute coronary syndrome, the potential for use in South-Asians remains largely unreported. As this ethnic group has a high rate of coronary events at a younger age, with more extensive and diffuse atheroma, the authors review the impact of statins in relation to observed lipid profiles, as well as novel markers of vascular disease.
J Rumi Jaumdally; Chetan Varma; Gregory Y H Lip
Related Documents :
3265059 - Aortic intimal lipid content and serum lipoproteins in patients undergoing coronary by-...
10634819 - Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients wit...
9012659 - Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estroge...
3737309 - Lipoproteins in the progeny of young men with coronary artery disease: children with in...
13130409 - Association between protease inhibitor use and increased cardiovascular risk in patient...
18783479 - Reduced leucocyte cholesteryl ester transfer protein expression in acute coronary syndr...
3707789 - Severe aortic stenosis in elderly patients.
15172299 - Marfan syndrome as a predisposing factor for traumatic aortic insufficiency.
24140379 - Timing in resolution of left heart dilation according to the degree of mitral regurgita...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  8     ISSN:  1744-7666     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-06-12     Completed Date:  2007-06-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  England    
Other Details:
Languages:  eng     Pagination:  1235-43     Citation Subset:  IM    
Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, B18 7QH, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Asia, Southeastern
Endothelium, Vascular / physiopathology
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects,  therapeutic use*
Hyperlipidemias / drug therapy*,  ethnology,  physiopathology,  prevention & control,  therapy
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Latest medical treatment strategies for venous thromboembolism.
Next Document:  Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections.